Open vs. Blind Weighing Study In Adolescents and Young Adult With Eating Disorders

Anorexia Nervosa Clinical Trial

Official title: Evaluating Open Weighing and Blind Weighing in the Treatment of Adolescents and Young Adults With Eating Disorders

Status Recruiting

Clinical Trial Summary

Current treatments for adolescents and young adults (AYAs) with eating disorders (EDs) do not effectively address a central ED symptom - anxiety about weight gain - which contributes to poor outcomes. The proposed study evaluates the feasibility, acceptability, efficacy, and underlying mechanisms of an enhanced version of "open weighing," a cognitive-behavioral intervention designed to target anxiety about weight gain in AYAs with EDs. Understanding how to better treat AYAs with EDs, and identifying the mechanisms by which interventions lead to improvement, will aid in the development of more effective and personalized treatments, ultimately improving the lives of AYAs with EDs.

Clinical Trial Description

The proposed study evaluates the feasibility, acceptability, efficacy, and underlying mechanisms of an enhanced version of "open weighing" (OW), a cognitive-behavioral intervention designed to target anxiety about weight gain in adolescents and young adults (AYAs) with eating disorders (EDs). OW will be compared to an alternative intervention, "blind weighing" (BW), in which individuals are discouraged from seeing, thinking, or talking about their weight. Understanding how to better treat AYAs with EDs, and identifying the mechanisms by which interventions lead to improvement, will aid in the development of more effective and personalized treatments, ultimately improving the lives of AYAs with EDs. Aim 1. Evaluate the feasibility and acceptability of OW and BW for AYAs with EDs. Hypothesis 1.1: Both OW and BW will be feasible, with no significant differences in rates of recruitment or retention. Hypothesis 1.2: Both treatments will be rated as highly acceptable, with no significant differences in measures evaluating the acceptability or attitudes about OW and BW. Aim 2. Test the efficacy of OW and BW. Hypothesis 2.1: OW will result in significantly greater improvements in body mass index and ED symptomatology than BW. Hypothesis 2.2: OW will result in significantly greater decreases in anxiety about weight gain than BW. Aim 3. Identify anxiety about weight gain as a key mechanism to target in the treatment of AYAs with EDs. Hypothesis 3.1: Across both conditions, greater reductions in anxiety about weight gain will be associated with better outcomes at discharge. ;

Related Conditions & MeSH terms

• Anorexia
• Anorexia Nervosa
• Eating Disorders
• Feeding and Eating Disorders

• NCT number: NCT06085092
• Study type: Interventional
• Source: Milton S. Hershey Medical Center
• Contact: Jamal Essayli, Ph.D
• Phone: 7175310003
• Email: jessayli@pennstatehealth.psu.edu
• Status: Recruiting
• Phase: N/A
• Start date: October 31, 2023
• Completion date: June 30, 2025